Conserved Interferon-γ Signaling Drives Clinical Response to Immune Checkpoint Blockade Therapy in Melanoma. uri icon

Overview

authors

publication date

  • December 10, 2020

Identity

PubMed Central ID

  • PMC7885306

Scopus Document Identifier

  • 85098205365

Digital Object Identifier (DOI)

  • 10.1016/j.ccell.2020.11.015

PubMed ID

  • 33306984

Additional Document Info

volume

  • 39

issue

  • 1